SCYNEXIS, Inc. (SCYX) Financials
SCYX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 148.5 million | 56.6 million |
2023-06-30 | 154.9 million | 61.8 million |
2023-03-31 | 70.3 million | 100.2 million |
2022-12-31 | 87.8 million | 84.6 million |
SCYX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | 12.4 million | 632000 |
2023-06-30 | 74.4 million | 728000 |
2023-03-31 | -18.9 million | 707000 |
2022-12-31 | -22.8 million | 454000 |
SCYX Net Income
No data available :(
SCYX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 88.1 million | - | 3.0 million |
2023-06-30 | 85.5 million | - | 3.1 million |
2023-03-31 | 54.8 million | - | 3.1 million |
2022-12-31 | 73.5 million | - | 3.2 million |
SCYX Shares Outstanding
SCYX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 6.5 million | 5.0 million | - |
2023-06-30 | - | 7.0 million | 7.5 million | - |
2023-03-31 | - | 6.8 million | 4.8 million | - |
2022-12-31 | 9000 | 7.8 million | 16.0 million | - |
SCYX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 1.8 million | 379000 |
2023-06-30 | 131.5 million | 426000 |
2023-03-31 | 1.1 million | 137000 |
2022-12-31 | 1.5 million | 196000 |
SCYX
Price: $1.72
52 week price:
Earnings Per Share: 1.49 USD
P/E Ratio: 1.33
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 45800
Ebitda: -8.0 millionMarket Capitalization: 60.6 million